Blocking a Small RNA Protects Neurons From Stroke-Like Injury in Cell Model

Cerebral ischemia-reperfusion injury, the wave of damage that strikes brain tissue when blood flow returns after a stroke, remains one of the most stubborn problems in neurology. A new study from researchers at the Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University Medical School, published in Frontiers in Molecular Neuroscience, points to a specific molecular culprit: a small regulatory RNA called miR-140-5p. According to the authors, blocking this microRNA in cultured cortical neurons substantially improved cell survival, synaptic integrity and inflammatory profiles after an experimental insult that mimics stroke, and they traced the protective effect to a single protein target and the signaling pathway it controls.

The work builds on the group’s earlier findings in living animals. Their previous studies showed that miR-140-5p expression rises markedly in the brain after cerebral ischemia, and that artificially overexpressing the microRNA in ischemic mouse models worsened cognitive impairment, suppressed the generation of new neurons and promoted neuronal death. What those experiments left open was the mechanism: which molecules miR-140-5p acts on, and how its overexpression translates into neuronal damage. The new study was designed to answer that question by identifying downstream targets.

To model ischemia-reperfusion in a controlled setting, the team established an oxygen-glucose deprivation and reoxygenation, or OGD/R, protocol in primary cortical neurons. In this model, neurons are deprived of oxygen and glucose to reproduce the metabolic crisis of ischemia and are then re-exposed to normal conditions, reproducing the reperfusion phase in which much of the injury actually occurs. Cell viability was quantified with a Cell Counting Kit-8 assay, a colorimetric readout of the number of metabolically active cells, allowing the researchers to track survival across experimental conditions.

The first key observation was that miR-140-5p was significantly upregulated in the mouse cortical neurons after OGD/R, mirroring the increase previously documented in ischemic brain tissue. The researchers then performed loss-of-function experiments, using inhibitors to suppress the microRNA’s activity. Functional inhibition of miR-140-5p markedly enhanced neuronal survival after the OGD/R challenge, indicating that the endogenous rise of the microRNA during the insult is not a harmless byproduct but an active contributor to injury.

Survival was not the only measure that improved. Synaptic integrity was assessed by immunofluorescence, a microscopy technique that uses fluorescently labeled antibodies to visualize specific proteins at synapses. In the miR-140-5p-inhibited neurons, the authors observed promoted synaptic remodeling, suggesting that silencing the microRNA helps neurons maintain or rebuild the connections that ischemic injury disrupts.

Inflammation provided a third line of evidence. The team measured inflammatory cytokines by enzyme-linked immunosorbent assay, or ELISA, an antibody-based method that quantifies secreted signaling proteins in the culture medium. Inhibition of miR-140-5p attenuated the inflammatory responses triggered by OGD/R, consistent with the idea that the microRNA amplifies the neuroinflammatory component of reperfusion injury rather than merely reflecting it.

The mechanistic core of the study came from proteomic analysis, an unbiased screen of the proteins expressed in the neurons that was used to identify potential downstream targets of miR-140-5p. That screen highlighted IL1RAPL1, a protein encoded by the Il1rapl1 gene. The researchers validated the interaction in two ways: Western blotting confirmed that IL1RAPL1 protein levels respond as predicted when miR-140-5p is manipulated, and dual-luciferase reporter assays, a standard molecular test in which a gene’s regulatory sequence is fused to a light-producing enzyme, demonstrated that miR-140-5p directly targets Il1rapl1. In other words, the microRNA binds the messenger RNA of Il1rapl1 and suppresses the production of the IL1RAPL1 protein.

Having established the target, the authors connected it to a signaling cascade. Their data indicate that miR-140-5p modulates downstream c-Jun N-terminal kinase, or JNK, signaling through its repression of IL1RAPL1. This regulation provides a coherent explanation for the observed effects on neuronal viability, inflammation and synaptic plasticity under ischemia-reperfusion conditions: when miR-140-5p rises, IL1RAPL1 falls, JNK signaling shifts, and neurons suffer; when the microRNA is inhibited, the sequence reverses.

The authors conclude that the study reveals a novel miR-140-5p-mediated regulatory mechanism in neuronal injury following cerebral ischemia-reperfusion and suggests a potential therapeutic target for ischemic brain injury. The findings are framed as preclinical and mechanistic rather than as a ready treatment. The experiments were performed in a cell culture model of OGD/R, which reproduces the metabolic and reoxygenation components of stroke but cannot capture the full complexity of blood-brain barrier disruption, immune cell infiltration and systemic physiology in living patients. The article’s final, formatted version was pending publication at the time of this coverage, and the authors note that all claims are solely their own and do not necessarily represent those of their affiliated organizations or the publisher.

Even with those caveats, the study offers a clear causal chain, from a stress-induced microRNA through a defined protein target to a named signaling pathway and measurable outcomes in neuronal survival, synapses and inflammation. Because the same microRNA was previously shown to worsen outcomes when overexpressed in ischemic mice, the convergence of in vivo and in vitro evidence strengthens the case that miR-140-5p inhibition deserves further testing as a strategy against ischemic brain injury. Future work in animal models will determine whether this molecular insight can be translated into therapy for stroke patients.

Subject of Research: The role of miR-140-5p and its target IL1RAPL1 in neuronal injury after ischemia-reperfusion

Article Title: Inhibition of miR-140-5p attenuates OGD/R-induced neuronal injury by targeting IL1RAPL1

Article References: Song, Y.-Y., Chen, Z.-J., Yan, H.-Y., & Zeng, L.-L. (2026). Inhibition of miR-140-5p attenuates OGD/R-induced neuronal injury by targeting IL1RAPL1. Frontiers in Molecular Neuroscience, 19, Article 1972044. https://doi.org/10.3389/fnmol.2026.1972044

Image Credits: AI Generated

DOI: 10.3389/fnmol.2026.1972044

Keywords: miR-140-5p, IL1RAPL1, JNK signaling, oxygen-glucose deprivation, cerebral ischemia-reperfusion, neuroinflammation, cortical neurons, microRNA, Inhibition, attenuates, R-induced, neuronal